Preview

Medical Immunology (Russia)

Advanced search

DYNAMIC CHANGES OF GRANULYSIN AND CATHELICIDIN IN CHILDREN AND ADOLESCENTS WITH DIFFERENT FORMS OF PULMONARY TUBERCULOSIS

https://doi.org/10.15789/1563-0625-2018-5-747-752

Abstract

Granulysin and cathelicidin, the cytolytic molecules of innate immune system are important protective factors during infection with Mycobacterium tuberculosis. We present original data concerning high levels of granulysin and cathelicidin among the group of children and adolescents with latent TB infection. Patients with tuberculosis of the respiratory system exhibit significantly lower amounts of serum cathelicidin in destructive forms, as well as granulysin levels in “minor” forms of tuberculosis before starting the specific chemotherapy. The chemotherapy performed did not influence the serum granulysin and cathelicidin contents in patients with destructive tuberculosis, whereas the patients with “minor” forms (TLN/focal tuberculosis) revealed a significant increase in granulysin content after 6 months of treatment, and same trend for cathelicidin concentrations after 3 months of chemotherapy, followed by subsequent return to baseline values.

About the Authors

M. M. (Jr) Averbakh
Central Research Institute for Tuberculosis.
Russian Federation

PhD, MD (Medicine), Professor, Main Research Associate, Department of Immunology,.

Moscow.


L. V. Panova
Central Research Institute for Tuberculosis.
Russian Federation

PhD, MD (Medicine), Senior Research Associate, Pediatric Department.

Moscow.


M. F. Gubkina
Central Research Institute for Tuberculosis.
Russian Federation

PhD, MD (Medicine), Senior Research Associate, Pediatric Department.

Moscow.


N. I. Evseeva
Central Research Institute for Tuberculosis.
Russian Federation

Junior Research Associate, Pediatric Department.

Moscow.


References

1. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood, 2000, Vol. 96, pp. 3086-3093.

2. Caccamo N., Meraviglia S., La Mendola C., Guggino G., Dieli F., Salerno A. Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. J. Immunol., 2006, Vol. 177, pp. 1780-1785.

3. Cakir E., Torun E., Gedik А.Н., Umutoglu T., Aktas E.C., Topuz U., Deniz G. Cathelicidin and human β-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis. Int. J. Tuberc. Lung. Dis., 2014, Vol. 18, pp. 671-675.

4. Castañeda-Delgado J., Hernández-Pando R., Serrano C.J., Aguilar-León D., León-Contreras J., Rivas- Santiago C., Méndez R., González-Curiel I., Enciso-Moreno A., Rivas-Santiago B. Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin. Exp. Immunol., 2010, Vol. 161, pp. 542-550.

5. Dheda K., Schwandre S.K., Zhu B., van Zyl-Smit S.K., Zhang V. The immunology of tuberculosis: From bench to bedside. Respirology, 2010, Vol. 15, pp. 433-450.

6. di Liberto D., Buccheri S., Caccamo N., Serena Meraviglia S., Amelia Romano A., di Carlo P., Titon L., Francesco Dieli F., Krensky AM.., Salerno A. Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy. Tuberculosis (Edinb), 2007, Vol. 87, pp. 322-328.

7. Fiske C.T., de Almeida C.N., Shintani А.К., Kalam A., Sterlinga T.R. Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis. Clin. Vaccine Immunol., 2012, Vol. 19, pp. 1142-1149.

8. Gansert J.L., Kiessler V., Engele M., Wittke F., Röllinghoff M., Krensky A.M., Porcelli S.A., Modlin R.L., Stenger S. Human NKT cells express granulysin and exhibit antimycobacterial activity. J. Immunol., 2003, Vol. 170, pp. 3154-3161.

9. Korbel D.S., Schneider B.E., Schaible U.E. Innate immunity in tuberculosis: myths and truth. Microbes Infect., 2008, Vol. 10, 995e1004. doi: 10.1016/j.micinf.2008.07.039.

10. Mueller H., Fae K.C., Magdorf M., Ganoza C.A., Wahn U., Guhlich U., Feiterna-Sperling C., Kaufmann S.H.E. Granulysin-еxpressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence. PLoS ONE, 2011, Vol. 6, Issue 12, e29367. doi: 10.1371/journal.pone.0029367.

11. Sahiratmadjaa Е., Alisjahbanad В., Buccherie S., Di Libertoe D., de Boera T., Adnanc I., van Crevelf R., Kleina M.R., van Meijgaardena K.E., Nelwang R.H.H., van de Vosseb E., Dielie F., Ottenhoff T.H.M. Plasma granulysin levels and cellular interferon-γ production correlate with curative host responses in tuberculosis, while plasma interferon-γ levels correlate with tuberculosis disease activity in adults. Tuberculosis, 2007, Vol. 87, pp. 312-321.

12. Selvaraj P. Vitamin D, vitamin D receptor, and cathelicidin in the treatment of tuberculosis. Vitam. Horm., 2011, Vol. 86, pp. 307-324.

13. Soehnlein O., Zernecke A., Eriksson E.E., Rothfuchs A.G., Pam C.T., Herwald H., Bidzhekov K., Rottenberg M.E., Weber C., Lindbom L. Neutrophil secretion products pave the way for inflammatory monocytes. Blood, 2008, Vol. 112, pp. 1461-1567.

14. Krensky A.M., Clayberger C. Biology and clinical relevance of granulysin. Tissue Antigens, 2009, Vol. 73, pp. 193-198.

15. Yamshchikov A.V., Kurbatova E.V., Kumari M., Blumberg H.M., Ziegler T.R., Ray S.M., Tangpricha V. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am. J. Clin. Nutr., 2010, Vol. 92, pp. 603-611.


Review

For citations:


Averbakh M.M., Panova L.V., Gubkina M.F., Evseeva N.I. DYNAMIC CHANGES OF GRANULYSIN AND CATHELICIDIN IN CHILDREN AND ADOLESCENTS WITH DIFFERENT FORMS OF PULMONARY TUBERCULOSIS. Medical Immunology (Russia). 2018;20(5):747-752. (In Russ.) https://doi.org/10.15789/1563-0625-2018-5-747-752

Views: 913


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)